Pinney & Scofield’s Pfizer PFE Stock Holding History

Pinney & Scofield’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149K	Hold	5,321	–	–	0.08%	65
2025 Q4	$132K	Hold	5,321	–	–	0.08%	64
2025 Q3	$136K	Hold	5,321	–	–	0.08%	59
2025 Q2	$129K	Hold	5,321	–	–	0.09%	65
2025 Q1	$135K	Hold	5,321	–	–	0.1%	61
2024 Q4	$141K	Buy	+5,321	New	+$144K	0.11%	59

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Pinney & Scofield's PFE Position: Q1 2026 in Review

Pinney & Scofield held its Pfizer (PFE) position steady in Q1 2026 at 5,321 shares worth $149K. The position accounts for 0.08% of the portfolio, ranked #65.

Pinney & Scofield first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Pinney & Scofield held 5,321 shares of Pfizer worth $149K as of Q1 2026.
Pinney & Scofield left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.08% of Pinney & Scofield's portfolio in Q1 2026, its #65 holding.
Pinney & Scofield first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Pinney & Scofield's 13F filing for Q1 2026, filed 15 May 2026.